Medium term
Trade view / 29 September 2015 at 4:34 GMT

Astra Zeneca shows medium-term vulnerability

Instrument: AZN:xome
Price target:
Market price:

Astra Zeneca (AZN:xome) listed on the Swedish stock exchange has been relatively strong during the most recent market turmoil but could be in for a medium-term setback.

As with many other stocks, the trend appears to be pointing lower as we have a sequence of lower highs and lower lows longer term. In the medium term, this stock has managed to bounce but has encountered trouble at the 200 and 50-day moving averages, which are both moving lower even though the 200-day ever so slightly. 

As of late the relative strength indicator (RSI) has turned lower with the rejection at the 50-day moving average yesterday.

Support is now found at SEK 537, SEK 525 and SEK 510. Resistance is located at the 50-day moving average and the 200-day at SEK 558 and SEK 570 respectively.

Now, a price break below SEK 537 would break the rising trend in the RSI indicator and is likely to move the indicator towards the 30 oversold threshold, which would mean the price in this case is likely to take the same path.

Management and risk description

The plan is to sell AZN:xome short below SEK 537 for a move into support at SEK 525 and SEK 510. Once we reach the first target level, consider taking partial profits and once we break below start to move the stop lower.

The risk to this setup is a quick break below support, which is immediately reversed. Ideally price will stay below support following a break lower.


Entry: sell below SEK 537.

Stop: SEK 560.

Target: SEK 525 and SEK 510.

Time horizon: two to three weeks.

AZN:xome daily chart
AZN:xome daily chart
AZN.xome daily development chart
AZN:xome daily development chart
 Source: all charts Saxo Bank. Create your own charts with SaxoTrader; click here to learn more. 

— Edited by Gayle Bryant

For more on equities click here

Non-independent investment research disclaimer applies. Read more


The Saxo Bank Group entities each provide execution-only service and access to permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on or as a result of the use of the Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. When trading through your contracting Saxo Bank Group entity will be the counterparty to any trading entered into by you. does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of ourtrading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws. Please read our disclaimers:
- Notification on Non-Independent Invetment Research
- Full disclaimer

Check your inbox for a mail from us to fully activate your profile. No mail? Have us re-send your verification mail